Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo.

Kabesha T, Van Dijck C, Mudwanga S, Houben S, Mujula Y, Munganga P, Tshomba JC, Mukari G, Wawina-Bokalanga T, Kinganda-Lusamaki E, Jacobs BK, Tsoumanis A, Vakaniaki EH, Rimoin AW, Brosius I, De Vos E, Bangwen E, Bracke S, Vercauteren K, Mwanza JC, Ngoma DB, Katoto P, Yeh S, Kabedi NN, Nussenblatt V, Tshiani-Mbaya O, Crozier I, Nundu SS, Kindrachuk J, Liesenborghs L, Mbala-Kingebeni P

Open source

DOI
10.1016/j.langlo.2026.104054
Published
2026 Aug 27
Container
The Lancet. Global health
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.langlo.2026.104054,
  title = {Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo.},
  author = {Kabesha T and Van Dijck C and Mudwanga S and Houben S and Mujula Y and Munganga P and Tshomba JC and Mukari G and Wawina-Bokalanga T and Kinganda-Lusamaki E and Jacobs BK and Tsoumanis A and Vakaniaki EH and Rimoin AW and Brosius I and De Vos E and Bangwen E and Bracke S and Vercauteren K and Mwanza JC and Ngoma DB and Katoto P and Yeh S and Kabedi NN and Nussenblatt V and Tshiani-Mbaya O and Crozier I and Nundu SS and Kindrachuk J and Liesenborghs L and Mbala-Kingebeni P},
  year = {2026},
  journal = {The Lancet. Global health},
  doi = {10.1016/j.langlo.2026.104054},
  url = {https://doi.org/10.1016/j.langlo.2026.104054}
}

RIS

TY  - JOUR
TI  - Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo.
AU  - Kabesha T
AU  - Van Dijck C
AU  - Mudwanga S
AU  - Houben S
AU  - Mujula Y
AU  - Munganga P
AU  - Tshomba JC
AU  - Mukari G
AU  - Wawina-Bokalanga T
AU  - Kinganda-Lusamaki E
AU  - Jacobs BK
AU  - Tsoumanis A
AU  - Vakaniaki EH
AU  - Rimoin AW
AU  - Brosius I
AU  - De Vos E
AU  - Bangwen E
AU  - Bracke S
AU  - Vercauteren K
AU  - Mwanza JC
AU  - Ngoma DB
AU  - Katoto P
AU  - Yeh S
AU  - Kabedi NN
AU  - Nussenblatt V
AU  - Tshiani-Mbaya O
AU  - Crozier I
AU  - Nundu SS
AU  - Kindrachuk J
AU  - Liesenborghs L
AU  - Mbala-Kingebeni P
PY  - 2026
JO  - The Lancet. Global health
DO  - 10.1016/j.langlo.2026.104054
UR  - https://doi.org/10.1016/j.langlo.2026.104054
ER  - 

APA

T, K., C, V. D., S, M., S, H., Y, M., P, M., JC, T., G, M., T, W., E, K., BK, J., A, T., EH, V., AW, R., I, B., E, D. V., E, B., S, B., K, V., JC, M., DB, N., P, K., S, Y., NN, K., V, N., O, T., I, C., SS, N., J, K., L, L., & P, M. (2026). Prevalence, characteristics, and clinical course of mpox-related ophthalmic disease (MBOTE-EYE): a prospective cohort study in South Kivu, Democratic Republic of the Congo.. The Lancet. Global health. https://doi.org/10.1016/j.langlo.2026.104054

Source records